
NYSE:KEYS
This summary was created by AI, based on 2 opinions in the last 12 months.
Keysight Technologies Inc. (KEYS-N) is a prominent measurement company, particularly in the realm of quantum technology, and plays a vital role in testing semiconductor chips prior to their market introduction. Experts recognize its significant position within the quantum stack, which aids in making necessary inferences regarding these technologies. While the current price target stands at $403, analysts suggest a more conservative target of $318.62, indicating a potential valuation challenge since buying is recommended at lower price points of $340 and $320. Additionally, Keysight is also involved in the natural gas sector, which may benefit from the ongoing AI infrastructure developments in the U.S., particularly with its capabilities in pipeline measurements.
Keysight Technologies Inc. is a American stock, trading under the symbol KEYS (previously KEYS-N on Stockchase) on the New York Stock Exchange (KEYS). It is usually referred to as NYSE:KEYS or KEYS
In the last year, 1 stock analyst published opinions about KEYS (previously KEYS-N on Stockchase). 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is WAIT. Read the latest stock experts' ratings for Keysight Technologies Inc..
Keysight Technologies Inc. was recommended as a Top Pick by Gordon Reid on 2021-07-14. Read the latest stock experts ratings for Keysight Technologies Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered Keysight Technologies Inc. in the last year. It is a trending stock that is worth watching.
On 2026-06-05, Keysight Technologies Inc. (KEYS) stock closed at a price of $329.83.
On the platform part of quantum -- middle part of the stack -- helps quantum make inferences. A measurement company, so it's one of the major players testing chips before they get rolled out.
(Analysts’ price target is $318.62)His 12-month price target is $403. May seem pricey, but keep it on your radar. Buy in thirds here, at $340, and at $320. No dividend.